Journals / Journal of Health Sciences and Medicine / 2022 / Cilt: 5 - Sayı: 4

The effect of the COVID-19 pandemic period on the cases of acute cholecystitis

Pages
966–968
Publication Date
2022-07-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The 2-year retrospective evaluation before and after the COVID-19 pandemic, a significant increase was found in cases of acute cholecystitis after the pandemic (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: A gallstone is a stone formed within the gallbladder out of precipitated bile components.
📊
Key Findings & Data:Material and Method: Patients who applied to hospital between 1st January 2018 and 1st January 2022 and were diagnosed with Acute Cholecystitis were retrospectively screened.
💡
Conclusion & Impact:Results: The 2-year retrospective evaluation before and after the COVID-19 pandemic, a significant increase was found in cases of acute cholecystitis after the pandemic (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Acute cholecystitis · COVID-19 · pandemic period

Abstract

Aim: A gallstone is a stone formed within the gallbladder out of precipitated bile components. Risk factors for gallstones include a family history of gallstones, age, genetic and environmental factors, sedentary lifestyle, high-fat diet, obesity. In this study, it was aimed to determine the effects of the pandemic process on acute cholecystitis cases. Material and Method: Patients who applied to hospital between 1st January 2018 and 1st January 2022 and were diagnosed with Acute Cholecystitis were retrospectively screened. The demographic data as age and sex were recorded by dividing the patients into two groups, two years before and two years after the COVID-19 pandemic period. Results: The 2-year retrospective evaluation before and after the COVID-19 pandemic, a significant increase was found in cases of acute cholecystitis after the pandemic (p

🔖

Cite This Article

SARIYILDIZ, G. T. (2022). The effect of the COVID-19 pandemic period on the cases of acute cholecystitis. Journal of Health Sciences and Medicine, Cilt: 5 - Sayı: 4, 966–968. https://ajindex.com/articles/776639

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Shaffer E. Epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 2006; 6: 981-6.
  2. Yoshida M, Hasegawa H, Norimizu S. Accuracy of the Tokyo Guidelines for the diagnosis of acutecholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. J Hepatobiliary Pancreat Sci 2011; 18: 250–7.
  3. Ateş B, Ünal İ. Kolesistit, Safra Taşları, Risk Faktörleri ve Beslenme İle İlişkisi. Güncel gastroenteroloji 2016; 20: 317-1.
  4. Laura M, Eldon A, Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut and Liver 2012; 2: 172-7. Menéndez-Sánchez P, León-Salinas C, Amo-Salas M, Méndez-Cea B, García-Carranza A.Association of laboratory and radiologic Parameters in the diagnosis of acute cholecystitis. Rev Gastroenterol Mex 2019; 84: 449-4.
  5. Pehlivan T, Alper Çevik A, Ateş E. Relationships among ultrasonographic and demographic, clinical, laboratory findings of patients with acute cholecystitis. Ulus Travma Acil Cerrahi Derg 2005; 11: 134-0. Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol 2018; 34: 81-9.
  6. Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol 2014; 28: 623-35.
  7. Constantinescu T, Huwood Al Jabouri AK, Brãtucu E, Olteanu C, Toma M, Stoiculescu A. Gallstone disease in young population: incidence, complications, therapeutic approach. Chirurgia (Bucur) 2012; 107: 579-82.
  8. Saleem Ansari, Hasan Haboubi, Nadim Haboubi. Adult obesity complications: challenges and clinical impact. Ther Adv Endocrinol Metab 2020; 11: 22 Mendez Sanchez N, Chavez Tapia C, Motola Kuba D. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005: 11: 1653–7.
  9. Ata N, Kucukazman M, Yavuz B. The metabolic syndrome is associated with complicated gallstone disease. Can J-Gastroenterol 2010; 25: 274-6.
  10. Mutlu P, Mirici A, Gönlügür U, et al. Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. J Health Sci Med 2022: 5; 544–551
  11. Tang Y, Hu L, Liu Y, et al. Possible mechanisms of cholesterol elevation aggravating COVID-19. Int J Med Sci 2021; 18: 3533-43
  12. Uyaroğlu O, Murat Özdede M, Başaran N, et al. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patients. J Health Sci Med 2022; 5: 220 - 26. Rathmann W, Kuss O, Kostev K. Incidence of newly diagnose